POLR vs. WWH, MYI, ATT, VEIL, N91, FEV, PNL, JTC, WTAN, and BRW
Should you be buying Polar Capital stock or one of its competitors? The main competitors of Polar Capital include Worldwide Healthcare (WWH), Murray International (MYI), Allianz Technology Trust (ATT), Vietnam Enterprise (VEIL), Ninety One Group (N91), Fidelity European Trust (FEV), Personal Assets (PNL), JTC (JTC), Witan Investment Trust (WTAN), and Brewin Dolphin (BRW). These companies are all part of the "asset management" industry.
Polar Capital vs. Its Competitors
Polar Capital (LON:POLR) and Worldwide Healthcare (LON:WWH) are both small-cap asset management industry companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.
Polar Capital pays an annual dividend of GBX 46 per share and has a dividend yield of 10.0%. Worldwide Healthcare pays an annual dividend of GBX 3 per share and has a dividend yield of 0.9%. Polar Capital pays out 107.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Worldwide Healthcare pays out 7.0% of its earnings in the form of a dividend.
In the previous week, Worldwide Healthcare had 1 more articles in the media than Polar Capital. MarketBeat recorded 1 mentions for Worldwide Healthcare and 0 mentions for Polar Capital. Worldwide Healthcare's average media sentiment score of 1.81 beat Polar Capital's score of 0.00 indicating that Worldwide Healthcare is being referred to more favorably in the news media.
51.1% of Polar Capital shares are held by institutional investors. Comparatively, 73.6% of Worldwide Healthcare shares are held by institutional investors. 15.0% of Polar Capital shares are held by company insiders. Comparatively, 0.4% of Worldwide Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Polar Capital presently has a consensus price target of GBX 555, suggesting a potential upside of 20.39%. Given Polar Capital's stronger consensus rating and higher possible upside, equities analysts plainly believe Polar Capital is more favorable than Worldwide Healthcare.
Worldwide Healthcare has a net margin of 92.78% compared to Polar Capital's net margin of 19.65%. Polar Capital's return on equity of 32.10% beat Worldwide Healthcare's return on equity.
Polar Capital has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, Worldwide Healthcare has a beta of 0.29, meaning that its share price is 71% less volatile than the S&P 500.
Worldwide Healthcare has higher revenue and earnings than Polar Capital. Worldwide Healthcare is trading at a lower price-to-earnings ratio than Polar Capital, indicating that it is currently the more affordable of the two stocks.
Summary
Polar Capital and Worldwide Healthcare tied by winning 9 of the 18 factors compared between the two stocks.
Get Polar Capital News Delivered to You Automatically
Sign up to receive the latest news and ratings for POLR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding POLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Polar Capital Competitors List
Related Companies and Tools
This page (LON:POLR) was last updated on 8/29/2025 by MarketBeat.com Staff